PathoQuest

PathoQuest is a global CRO that specializes in biopharma Quality Control (QC) based on Next-Generation Sequencing (NGS) for viral safety and genetic characterization. The company’s proprietary NGS-based testing approach delivers actionable QC reports to the industry for cell & gene therapy, vaccines and biologics.

With a proven track record, our expert team can support fast and robust QC testing at a GMP grade over two facilities in Europe (Paris, FR) and in the U.S. (Wayne, PA).

PathoQuest is at the forefront of NGS-based testing solutions that accelerate the commercial availability of biopharmaceuticals and can replace current standardized in vivo and in vitro testing options.

Biopharma Quality Control

Faster, Safer, Animal-Free.